1. Home
  2. IMMP vs BPRN Comparison

IMMP vs BPRN Comparison

Compare IMMP & BPRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • BPRN
  • Stock Information
  • Founded
  • IMMP 1987
  • BPRN 2007
  • Country
  • IMMP Australia
  • BPRN United States
  • Employees
  • IMMP N/A
  • BPRN N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • BPRN Major Banks
  • Sector
  • IMMP Health Care
  • BPRN Finance
  • Exchange
  • IMMP Nasdaq
  • BPRN Nasdaq
  • Market Cap
  • IMMP 244.5M
  • BPRN 216.1M
  • IPO Year
  • IMMP N/A
  • BPRN N/A
  • Fundamental
  • Price
  • IMMP $1.80
  • BPRN $30.24
  • Analyst Decision
  • IMMP Buy
  • BPRN Strong Buy
  • Analyst Count
  • IMMP 1
  • BPRN 1
  • Target Price
  • IMMP $7.00
  • BPRN $35.00
  • AVG Volume (30 Days)
  • IMMP 69.1K
  • BPRN 7.9K
  • Earning Date
  • IMMP 02-27-2025
  • BPRN 07-24-2025
  • Dividend Yield
  • IMMP N/A
  • BPRN 3.82%
  • EPS Growth
  • IMMP N/A
  • BPRN N/A
  • EPS
  • IMMP N/A
  • BPRN 1.00
  • Revenue
  • IMMP $3,019,249.00
  • BPRN $68,942,000.00
  • Revenue This Year
  • IMMP $50.37
  • BPRN $14.19
  • Revenue Next Year
  • IMMP N/A
  • BPRN $15.48
  • P/E Ratio
  • IMMP N/A
  • BPRN $31.43
  • Revenue Growth
  • IMMP 24.11
  • BPRN N/A
  • 52 Week Low
  • IMMP $1.32
  • BPRN $27.25
  • 52 Week High
  • IMMP $2.72
  • BPRN $39.35
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 59.33
  • BPRN 40.19
  • Support Level
  • IMMP $1.60
  • BPRN $31.54
  • Resistance Level
  • IMMP $1.83
  • BPRN $31.64
  • Average True Range (ATR)
  • IMMP 0.05
  • BPRN 0.76
  • MACD
  • IMMP 0.02
  • BPRN -0.25
  • Stochastic Oscillator
  • IMMP 84.78
  • BPRN 6.49

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About BPRN Princeton Bancorp Inc. (PA)

Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.

Share on Social Networks: